$IHT

WIRTH JAMES F sold $17K of IHT

WIRTH JAMES F (President & CEO) sold 12,378 shares of INNSUITES HOSPITALITY TRUST (IHT) at $1.40 on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WIRTH JAMES F
Published Aug 27, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IHT
Neutral
high confidence
Mentioned
$IHT
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IHTNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, suggesting limited informational value for traders.

02

Market read

Low relevance; the insider sale is small and unlikely to affect market perception.

03

What to watch

The sale was pre‑arranged under a 10b5‑1 plan, reducing the likelihood of a negative signal.

Relevance 2/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$IHTNeutralHigh confidence
Context

CEO James Wirth sold 12,378 shares for $17,372 via a 10b5-1 plan, reducing his stake to 8,033,386 shares.

Expected impact

No significant price change expected.

Evidence & confidence

The sale amount is small relative to the trust's market cap and typical daily volume, so market impact is minimal.

Market effects

None; the transaction is specific to IHT and does not affect the broader REIT sector.

None; limited to the trust's shareholders.

None

Counterpoint

Even small insider sales can signal concerns about future performance.

Key entities

  • James Wirth

    President & CEO of Innsuites Hospitality Trust

  • Innsuites Hospitality Trust

    Real estate investment trust focused on hospitality assets

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).